The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by García-Peydró, M.
Right arrow Articles by López de Castro, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by García-Peydró, M.
Right arrow Articles by López de Castro, J. A.
The Journal of Immunology, 1999, 163: 6060-6064.
Copyright © 1999 by The American Association of Immunologists

Peptide Presentation to an Alloreactive CTL Clone Is Modulated Through Multiple Mechanisms Involving Polymorphic and Conserved Residues in HLA-B271

Marina García-Peydró, Alberto Paradela, José R. Lamas and José A. López de Castro2

Centro de Biología Molecular Severo Ochoa, (Consejo Superior de Investigaciones Cientificas, Universidad Autónoma de Madrid, Facultad de Ciencias, Madrid, Spain

This study addressed the mechanisms by which HLA class I polymorphism modulates allorecognition. CTL 27S69 is an alloreactive clone raised against HLA-B*2705, with a known peptide epitope. This CTL cross-reacts with B*2702, which differs from B*2705 in the D77N, T80I, and L81A changes, but not with B*2701, which has D74Y, D77N, and L81A changes. To explain this differential recognition, B*2705 mutants mimicking subtype changes were used. The A81 mutant was not recognized, despite binding the natural epitope in vivo, suggesting that, when bound to this mutant, this peptide adopts an inappropriate conformation. The N77 and I80 mutations restored recognition in the N77A81 or I80A81 mutants. These compensatory effects explain the cross-reaction with B*2702. The Y74 and the Y74N77 mutants were weakly recognized or not recognized by CTL 27S69. This correlated with the absence or marginal presence of the peptide epitope in the Y74N77-bound pool. As with B*2701, exogenous addition of the peptide epitope sensitized Y74 and Y74N77 targets for lysis, indicating that failure to cross-react with B*2701 or these mutants was due to poor binding of the peptide in vivo and not to inappropriate presentation. The abrogating effect of Y74 was critically dependent upon the K70 residue, conserved among subtypes, as demonstrated with mutants at this position. Thus, HLA polymorphism affects allorecognition by modulating peptide binding or the conformation of bound peptides. Compensatory mutations and indirect effects of a polymorphic residue on residues conserved play a critical role.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. M. E. Whitelegg, L. E. M. Oosten, S. Jordan, M. Kester, A. G. S. van Halteren, J. A. Madrigal, E. Goulmy, and L. D. Barber
Investigation of Peptide Involvement in T Cell Allorecognition Using Recombinant HLA Class I Multimers
J. Immunol., August 1, 2005; 175(3): 1706 - 1714.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Hu, N. M. Cladel, M. D. Pickel, and N. D. Christensen
Amino Acid Residues in the Carboxy-Terminal Region of Cottontail Rabbit Papillomavirus E6 Influence Spontaneous Regression of Cutaneous Papillomas
J. Virol., October 25, 2002; 76(23): 11801 - 11808.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Popov, C. S. Dela Cruz, B. H. Barber, B. Chiu, and R. D. Inman
Breakdown of CTL Tolerance to Self HLA-B*2705 Induced by Exposure to Chlamydiatrachomatis
J. Immunol., October 1, 2002; 169(7): 4033 - 4038.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Reinelt, M. Marti, S. Dedier, T. Reitinger, G. Folkers, J. A. L. de Castro, and D. Rognan
beta -Amino Acid Scan of a Class I Major Histocompatibility Complex-restricted Alloreactive T-cell Epitope
J. Biol. Chem., June 29, 2001; 276(27): 24525 - 24530.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.